Buckingham Capital Management (Ohio)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $213K | Sell |
8,030
-5,270
| -40% | -$143K | 0.02% | 127 |
|
|
2024
Q3 | $385K | Sell |
13,300
-171
| -1% | -$4.99K | 0.04% | 111 |
|
|
2024
Q2 | $377K | Sell |
13,471
-319
| -2% | -$8.78K | 0.05% | 106 |
|
|
2024
Q1 | $383K | Buy |
+13,790
| New | +$383K | 0.05% | 108 |
|
|
2023
Q4 | – | Sell |
-6,262
| Closed | -$208K | – | 121 |
|
|
2023
Q3 | $208K | Buy |
6,262
+33
| +0.5% | +$1.17K | 0.03% | 108 |
|
|
2023
Q2 | $228K | Buy |
6,229
+65
| +1% | +$2.53K | 0.03% | 105 |
|
|
2023
Q1 | $251K | Buy |
6,164
+15
| +0.2% | +$648 | 0.04% | 98 |
|
|
2022
Q4 | $315K | Sell |
6,149
-800
| -12% | -$38.4K | 0.05% | 94 |
|
|
2022
Q3 | $304K | Hold |
6,949
| – | – | 0.06% | 95 |
|
|
2022
Q2 | $364K | Sell |
6,949
-350
| -5% | -$17.8K | 0.07% | 93 |
|
|
2022
Q1 | $378K | Sell |
7,299
-88
| -1% | -$4.57K | 0.06% | 94 |
|
|
2021
Q4 | $436K | Sell |
7,387
-100
| -1% | -$4.96K | 0.07% | 94 |
|
|
2021
Q3 | $322K | Sell |
7,487
-300
| -4% | -$13.3K | 0.05% | 96 |
|
|
2021
Q2 | $305K | Sell |
7,787
-930
| -11% | -$36.2K | 0.05% | 103 |
|
|
2021
Q1 | $316K | Sell |
8,717
-43
| -0.5% | -$1.53K | 0.05% | 101 |
|
|
2020
Q4 | $322K | Sell |
8,760
-12,477
| -59% | -$458K | 0.06% | 101 |
|
|
2020
Q3 | $739K | Sell |
21,237
-429
| -2% | -$15K | 0.15% | 79 |
|
|
2020
Q2 | $672K | Sell |
21,666
-6,075
| -22% | -$206K | 0.15% | 82 |
|
|
2020
Q1 | $859K | Sell |
27,741
-29,502
| -52% | -$1.01M | 0.22% | 72 |
|
|
2019
Q4 | $2.13M | Sell |
57,243
-5,049
| -8% | -$180K | 0.37% | 57 |
|
|
2019
Q3 | $2.12M | Sell |
62,292
-3,970
| -6% | -$144K | 0.39% | 58 |
|
|
2019
Q2 | $2.72M | Sell |
66,262
-6,016
| -8% | -$239K | 0.52% | 53 |
|
|
2019
Q1 | $2.91M | Sell |
72,278
-9,648
| -12% | -$386K | 0.57% | 49 |
|
|
2018
Q4 | $3.39M | Sell |
81,926
-4,819
| -6% | -$200K | 0.74% | 42 |
|
|
2018
Q3 | $3.63M | Sell |
86,745
-19,296
| -18% | -$743K | 0.71% | 41 |
|
|
2018
Q2 | $3.65M | Sell |
106,041
-25,918
| -20% | -$886K | 0.74% | 39 |
|
|
2018
Q1 | $4.44M | Sell |
131,959
-2,024
| -2% | -$69.6K | 0.93% | 24 |
|
|
2017
Q4 | $4.6M | Sell |
133,983
-929
| -0.7% | -$31.7K | 0.97% | 23 |
|
|
2017
Q3 | $4.57M | Buy |
134,912
+5,393
| +4% | +$173K | 1.01% | 20 |
|
|
2017
Q2 | $4.13M | Buy |
129,519
+10,237
| +9% | +$323K | 0.95% | 22 |
|
|
2017
Q1 | $3.87M | Buy |
119,282
+9,841
| +9% | +$310K | 0.91% | 24 |
|
|
2016
Q4 | $3.37M | Buy |
109,441
+834
| +0.8% | +$25.5K | 0.84% | 28 |
|
|
2016
Q3 | $3.49M | Buy |
108,607
+7,304
| +7% | +$244K | 0.89% | 26 |
|
|
2016
Q2 | $3.38M | Buy |
101,303
+6,171
| +6% | +$197K | 0.9% | 26 |
|
|
2016
Q1 | $2.67M | Buy |
95,132
+7,424
| +8% | +$212K | 0.73% | 35 |
|
|
2015
Q4 | $2.69M | Buy |
87,708
+4,687
| +6% | +$147K | 0.75% | 34 |
|
|
2015
Q3 | $2.47M | Buy |
83,021
+7,625
| +10% | +$244K | 0.73% | 33 |
|
|
2015
Q2 | $2.41M | Buy |
75,396
+6,959
| +10% | +$227K | 0.67% | 39 |
|
|
2015
Q1 | $2.26M | Buy |
68,437
+9,035
| +15% | +$287K | 0.65% | 43 |
|
|
2014
Q4 | $1.76M | Buy |
59,402
+4,909
| +9% | +$141K | 0.52% | 55 |
|
|
2014
Q3 | $1.53M | Buy |
54,493
+18,616
| +52% | +$522K | 0.48% | 70 |
|
|
2014
Q2 | $1.01M | Buy |
35,877
+4,831
| +16% | +$138K | 0.32% | 100 |
|
|
2014
Q1 | $946K | Sell |
31,046
-46
| -0.1% | -$1.37K | 0.32% | 99 |
|
|
2013
Q4 | $904K | Buy |
31,092
+859
| +3% | +$25K | 0.32% | 98 |
|
|
2013
Q3 | $828K | Sell |
30,233
-1,781
| -6% | -$48.5K | 0.34% | 102 |
|
|
2013
Q2 | $851K | Buy |
+32,014
| New | +$885K | 0.35% | 90 |
|
Other funds holding PFE
Buckingham Capital Management (Ohio)'s PFE Position: Q4 2024 in Review
Buckingham Capital Management (Ohio) reduced its Pfizer (PFE) stake by 40% in Q4 2024, selling an estimated $143K and leaving 8,030 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #127.
Buckingham Capital Management (Ohio) first reported a position in PFE in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.6M in Q4 2017. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Buckingham Capital Management (Ohio) held 8,030 shares of Pfizer worth $213K as of Q4 2024.
- Buckingham Capital Management (Ohio) sold 5,270 Pfizer shares in Q4 2024, an estimated $143K.
- Pfizer made up 0.02% of Buckingham Capital Management (Ohio)'s portfolio in Q4 2024, its #127 holding.
- Buckingham Capital Management (Ohio) first reported a position in Pfizer in Q2 2013 and has held it in 46 quarters since.
- Buckingham Capital Management (Ohio)'s Pfizer position peaked at $4.6M in Q4 2017.
- 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Buckingham Capital Management (Ohio)'s 13F filing for Q4 2024, filed 31 Jan 2025.